This clinical study is sponsored by Neuren Pharmaceuticals, a biopharmaceutical company headquartered in Melbourne, Australia focusing on the development of therapies for neurodevelopmental and neurodegenerative disorders. Current trials target neurodevelopmental disorders such as Phelan-McDermid, Angelman, and Pitt Hopkins syndromes.

For more information on these upcoming studies, please visit

For more information on Neuren Pharmaceuticals, visit

Further information provided by other websites and organizations for additional resources about Phelan-McDermid syndrome can be found below.

PMSF (Phelan-McDermid Syndrome Foundation)

PMSF has a mission to improve the quality of life of people affected by Phelan-McDermid syndrome worldwide by providing family support, accelerating research, and raising awareness.

More information can be found at is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world, according to their website. The service is supported by the National Institutes of Health.

You can find our entry at:

Reimbursement Information

PMSF will administer funds to support families for their participation in this Phelan-McDermid syndrome study.

If you are interested in receiving travel support towards participation in the study, or would like further information, please contact the PMSF directly via .

In order to ensure that we’re able to support future families in this trial, it may not be possible to approve 100% of your estimated expenses, but we will do our best to meet your needs. Thank you for your understanding and dedication to advancing research for Phelan-McDermid syndrome.

Contact Us To Learn More

PMS Study Recruitment is now Closed.
Thank you to all the families who participated!